Trimetazidine and Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy
This randomized clinical trial at a tertiary referral center in the United Kingdom compares the effects of oral trimetazidine hydrochloride vs placebo on exercise capacity among patients with nonobstructive hypertrophic cardiomyopathy.